The Outlook for Weight-Loss Drugs Just Got 'Turbocharged.' It's Good for Eli Lilly, Novo Nordisk.
New trial data for Novo Nordisk's Wegovy drug could herald a paradigm shift in weight-loss treatments.
Source: marketwatch.com
Page 40 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Service Testing Today - Breaking & Trending Today
Health Care Up as Novo Nordisk, Eli Lilly Rally Continues -- Health Care Roundup
Health-care companies rose as traders continued to chase gains in obesity-drug makers. Novo Nordisk shares rose slightly after the Danish drug giant said its...
Source: marketwatch.com
Diabetes stocks are surprise winners from Novo Nordisk's Wegovy study, analysts say
Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits
Source: marketwatch.com
Novo Nordisk's Wegovy cuts risk of heart attack, stroke by 20%, study finds
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say
Source: marketwatch.com
Here's how Eli Lilly might bring a game-changing Alzheimer's drug to market
Also: Bad and good results this earnings season, new tax rules, stock picks and how you too can be a mortgage lender.
Source: marketwatch.com